LIGAND PHARMACEUTICALS INCORPORATED Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease)
LIGAND PHARMACEUTICALS INCORPORATED (LGNXZ) reported Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) of $200.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › and Others
us-gaap:AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease · last filed 2026-08-07
- LIGAND PHARMACEUTICALS INCORPORATED accounts receivable, allowance for credit loss, period increase (decrease) for the quarter ending 2026-06-30 was $200.00K, a 100.00% increase year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED accounts receivable, allowance for credit loss, period increase (decrease) for the quarter ending 2026-03-31 was -$200.00K, a 166.67% decline year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED accounts receivable, allowance for credit loss, period increase (decrease) for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED accounts receivable, allowance for credit loss, period increase (decrease) for the quarter ending 2025-09-30 was $300.00K.
- LIGAND PHARMACEUTICALS INCORPORATED accounts receivable, allowance for credit loss, period increase (decrease) for fiscal 2025 was $400.00K.
- LIGAND PHARMACEUTICALS INCORPORATED accounts receivable, allowance for credit loss, period increase (decrease) for fiscal 2024 was -$200.00K, a 166.67% decline from fiscal 2023.
- LIGAND PHARMACEUTICALS INCORPORATED accounts receivable, allowance for credit loss, period increase (decrease) for fiscal 2023 was $300.00K.
- LIGAND PHARMACEUTICALS INCORPORATED accounts receivable, allowance for credit loss, period increase (decrease) for fiscal 2022 was -$300.00K, a 3100.00% decline from fiscal 2021.
| Period end | Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) 3 month | Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) 3 month as first filed | Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) 6 month | Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) 6 month as first filed | Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) 9 month | Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) 9 month as first filed | Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) 12 month | Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $200.00K 10-Q · filed 2026-08-07 | $30.00K 10-Q · filed 2026-08-07 | $0.00 derived: sum of 3 quarters · filed 2026-08-07 | $300.00K derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2026-03-31 | -$200.00K 10-Q · filed 2026-05-08 | -$200.00K derived: sum of 2 quarters · filed 2026-05-08 | $100.00K derived: sum of 3 quarters · filed 2026-05-08 | $200.00K derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $300.00K derived: sum of 2 quarters · filed 2026-02-27 | $400.00K derived: sum of 3 quarters · filed 2026-08-07 | $400.00K 10-K · filed 2026-02-27 | ||||
| 2025-09-30 | $300.00K 10-Q · filed 2025-11-07 | $400.00K derived: sum of 2 quarters · filed 2026-08-07 | $400.00K 10-Q · filed 2025-11-07 | $800.00K derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-06-30 | $100.00K 10-Q · filed 2026-08-07 | $400.00K 10-Q · filed 2026-08-07 | $500.00K derived: sum of 3 quarters · filed 2026-08-07 | $300.00K derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-03-31 | $300.00K 10-Q · filed 2026-05-08 | $400.00K derived: sum of 2 quarters · filed 2026-05-08 | $200.00K derived: sum of 3 quarters · filed 2026-05-08 | $400.00K derived: sum of 4 quarters · filed 2026-05-08 | ||||
| 2024-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$100.00K derived: sum of 2 quarters · filed 2026-02-27 | $100.00K derived: sum of 3 quarters · filed 2026-02-27 | -$200.00K 10-K · filed 2026-02-27 | -$100.00K 10-K · filed 2025-02-28 | |||
| 2024-09-30 | -$200.00K 10-Q · filed 2025-11-07 | -$10.00K 10-Q · filed 2024-11-08 | $0.00 derived: sum of 2 quarters · filed 2025-11-07 | -$300.00K 10-Q · filed 2025-11-07 | -$130.00K 10-Q · filed 2024-11-08 | -$140.00K derived: sum of 4 quarters · filed 2026-02-27 | ||
| 2024-06-30 | $200.00K 10-Q · filed 2025-08-08 | $180.00K 10-Q · filed 2024-08-07 | -$100.00K 10-Q · filed 2025-08-08 | -$120.00K 10-Q · filed 2024-08-07 | $60.00K derived: sum of 3 quarters · filed 2026-02-27 | $160.00K derived: sum of 4 quarters · filed 2026-02-27 | ||
| 2024-03-31 | -$300.00K 10-Q · filed 2025-05-09 | -$140.00K derived: sum of 2 quarters · filed 2026-02-27 | -$40.00K derived: sum of 3 quarters · filed 2026-02-27 | -$130.00K derived: sum of 4 quarters · filed 2026-02-27 | ||||
| 2023-12-31 | $160.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $260.00K derived: sum of 2 quarters · filed 2026-02-27 | $170.00K derived: sum of 3 quarters · filed 2026-02-27 | $300.00K 10-K · filed 2026-02-27 | $200.00K 10-K · filed 2024-02-29 | |||
| 2023-09-30 | $100.00K 10-Q · filed 2024-11-08 | $10.00K derived: sum of 2 quarters · filed 2024-11-08 | $140.00K 10-Q · filed 2024-11-08 | |||||
| 2023-06-30 | -$90.00K 10-Q · filed 2024-08-07 | $50.00K 10-Q · filed 2024-08-07 | ||||||
| 2023-03-31 | $100.00K 10-Q · filed 2024-05-08 | |||||||
| 2022-12-31 | -$300.00K 10-K · filed 2025-02-28 | |||||||
| 2021-12-31 | $10.00K 10-K · filed 2024-02-29 |